title: Variation in care for recurrent nonmelanoma skin cancer in a university-based practice and a veterans affairs clinic.
abstract: OBJECTIVE
  To learn if treatment of recurrent nonmelanoma skin cancer (NMSC) varied in different practice settings.
  
  
  METHODS
  Prospective cohort study of consecutive patients with recurrent NMSC.
  
  
  METHODS
  A university-based dermatology practice and the dermatology clinic at the affiliated Veterans Affairs Medical Center (VAMC). Conventional therapies for NMSC were available at both sites. Patients All 191 patients diagnosed as having recurrent NMSC in 1999 and 2000 were included in the study. Data were collected from medical record review and surveys mailed to patients. Main Outcome Measure Performance of Mohs micrographic surgery (Mohs).
  
  
  RESULTS
  Patients at the VAMC were older, less educated, poorer, and had more comorbid illnesses, but their tumors were similar to those of patients at the university-based practice. Treatment choices differed at the 2 sites: the proportions of tumors treated in the VAMC and university sites were 60% and 14%, respectively, for excisional surgery; and 24% and 61%, respectively, for Mohs (P < .001). In multivariate analyses adjusting for patient, tumor, and physician features that may have affected treatment choice, tumors treated at the university-based site remained significantly more likely to be treated with Mohs (odds ratio, 8.68 [95% confidence interval, 3.66-20.55]; P < .001).
  
  
  CONCLUSIONS
  Substantial variation existed in the treatment of recurrent NMSC in different practice settings. This variation was not explained by measured clinical characteristics of the patients or the tumors.
authors.affiliation: Department of Dermatology, Stanford University MedicalCenter, Stanford, California, USA.
authors.forename: F Landon
authors.initials: FL
authors.lastname: Clark
authors.forename: Anju
authors.initials: A
authors.lastname: Sahay
authors.forename: Daniel
authors.initials: D
authors.lastname: Bertenthal
authors.forename: Leah
authors.initials: L
authors.lastname: Maddock
authors.forename: Karla
authors.initials: K
authors.lastname: Lindquist
authors.forename: Roy
authors.initials: R
authors.lastname: Grekin
authors.forename: Mary-Margaret
authors.initials: MM
authors.lastname: Chren
mesh_terms: D000046:Academic Medical Centers; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D005260:Female; D006787:Hospitals, Veterans; D006801:Humans; D008297:Male; D008875:Middle Aged; D015580:Mohs Surgery / Q000706:statistics & numerical data; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D010044:Outpatient Clinics, Hospital; D011364:Professional Practice; D011446:Prospective Studies; D012878:Skin Neoplasms / Q000601:surgery*
references.citation: Med Care. 1996 Mar;34(3):220-33
references.pmid: 8628042
references.citation: Dermatol Surg. 2002 Mar;28(3):268-73
references.pmid: 11896781
references.citation: Br J Dermatol. 2004 Jul;151(1):141-7
references.pmid: 15270883
references.citation: Lancet. 2004 Nov 13-19;364(9447):1766-72
references.pmid: 15541449
references.citation: Arch Dermatol. 2000 Nov;136(11):1318-24
references.pmid: 11074691
references.citation: Med Care. 2004 Oct;42(10):1019-26
references.pmid: 15377935
references.citation: J Dermatol Surg Oncol. 1989 Apr;15(4):424-31
references.pmid: 2925988
references.citation: Med Care. 1996 Jan;34(1):73-84
references.pmid: 8551813
references.citation: Cochrane Database Syst Rev. 2003;(2):CD003412
references.pmid: 12804465
references.citation: Lancet. 2005 Apr 2-8;365(9466):1226-7; author reply 1227
references.pmid: 15811449